|
"lee yc"的相關文件
顯示項目 321-330 / 445 (共45頁)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
每頁顯示[10|25|50]項目
| 高雄醫學大學 |
2005 |
三種非侵襲性幽門桿菌檢測法在孩童之比較?
|
郭昭宏;盧建宇;蘇育正;余方榮;李易諶;楊淵傑;吳宜珍;王聖雯;黃玉燕;楊曉芳;張玲麗;莊捷翰;詹昌明;王文明;吳登強; Kuo, CH;Lu, CY;Su, YC;Yu, FJ;Lee, YC;Yang, YC;Wu, IC;Wang, SW;Huang, YY;Yang, SF;Chang, LL;Chuang, CH;Jan, CM;Wang, WM;Wu DC |
| 中國醫藥大學 |
2004-12-06 |
The Application of RFID in Emergency Medicine
|
蔡文正; (Kuo F); (Lee YC); (Wu F); (Ku CY) |
| 國家衛生研究院 |
2004-10-18 |
Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones
|
Chern, JH; Lee, CC; Chang, CS; Lee, YC; Tai, CL; Lin, YT; Shia, KS; Lee, CY; Shih, SR |
| 國家衛生研究院 |
2004-10 |
Biosynthesis of human-type N-glycans in heterollogous systems
|
Betenbaugh, MJ; Tomiya, N; Narang, S; Hsu, JTA; Lee, YC |
| 國家衛生研究院 |
2004-09 |
Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone
|
Shih, SR; Tsai, MC; Tseng, SN; Won, KF; Shia, KS; Li, WT; Chern, JH; Chen, GW; Lee, CC; Lee, YC; Peng, KC; Chao, YS |
| 國立臺灣大學 |
2004-07 |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.
|
Tsuei, DJ; Hsu, HC; Lee, PH; Jeng, YM; Pu, YS; Chen, CN; Lee, YC; Chou, WC; Chang, CJ; Ni, YH; Chang, MH. |
| 國家衛生研究院 |
2004-06-14 |
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
|
Lee, YC; Wu, CT; Shih, JY; Jou, YS; Chang, YL |
| 國家衛生研究院 |
2004-05-17 |
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors
|
Chern, JH; Shia, KS; Hsu, TA; Tai, CL; Lee, CC; Lee, YC; Chang, CS; Tseng, SN; Shih, SR |
| 國家衛生研究院 |
2004-03-08 |
Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives
|
Chern, JH; Shia, KS; Chang, CM; Lee, CC; Lee, YC; Tai, CL; Lin, YT; Chang, CS; Tseng, HY |
| 國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
顯示項目 321-330 / 445 (共45頁)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
每頁顯示[10|25|50]項目
|
